Literature DB >> 28959317

The Effects of Organic Solvents on the Physicochemical Properties of Human Serum Albumin Nanoparticles.

Hossein Mohammad-Beigi1, Seyed Abbas Shojaosadati1, Dina Morshedi2, Negar Mirzazadeh1, Ayyoob Arpanaei2.   

Abstract

BACKGROUND: Recently, applications of albumin nanoparticles as drug delivery carriers have increased. Most toxicology studies have shown that surface chemistry and size of nanoparticles play an important role in biocompatibility and toxicity.
OBJECTIVE: The effect of desolvating agents with different chemical properties on the size of synthesized HSA NPs was investigated.
MATERIALS AND METHODS: Acetone, ethanol, methanol, and acetonitrile were used to synthesize HSA NPs with controllable size by desolvation method. Scanning electron microscopy (SEM), dynamic light scattering (DLS), and circular dichroism (CD) were employed to characterize produced particles. Finally, the toxicity of HSA NPs synthesized under different conditions was evaluated on PC-12 cells.
RESULTS: The sizes of synthesized particles differed according to the different solvents used. The sizes were 275.3 nm, 155.3 nm, 100.11 nm, and 66.2 nm for acetonitrile, ethanol, acetone, and methanol, respectively. CD showed that larger NPs had more changes in the secondary structures. Finally, the toxicity monitored on the cultured PC-12 cells showed no significant toxic effect through treating with these NPs at different concentrations (0-500 μg.mL-1).
CONCLUSIONS: The size of HSA NPs has a strong dependency on the desolvating agent. The mechanism in which the desolvating agent affects the size of HSA NPs is complex. Various factors such as dielectric constant, polarity, functional groups, and hydrogen bonding of the solvents have the potential to affect the size and structure of HSA NPs. CD analysis suggested that the solvent denaturing capability had a critical effect on the HSA particle size. The stronger denaturing capability of the solvent resulted in the larger HSA particle size.

Entities:  

Keywords:  Desolvating agents; Human serum albumin nanoparticles; Physicochemical properties

Year:  2016        PMID: 28959317      PMCID: PMC5435013          DOI: 10.15171/ijb.1168

Source DB:  PubMed          Journal:  Iran J Biotechnol        ISSN: 1728-3043            Impact factor:   1.671


  19 in total

1.  Optimization of the preparation process for human serum albumin (HSA) nanoparticles.

Authors:  K Langer; S Balthasar; V Vogel; N Dinauer; H von Briesen; D Schubert
Journal:  Int J Pharm       Date:  2003-05-12       Impact factor: 5.875

2.  Albumin nanoparticles carrying cyclodextrins for nasal delivery of the anti-Alzheimer drug tacrine.

Authors:  Barbara Luppi; Federica Bigucci; Giuseppe Corace; Alice Delucca; Teresa Cerchiara; Milena Sorrenti; Laura Catenacci; Anna Maria Di Pietra; Vittorio Zecchi
Journal:  Eur J Pharm Sci       Date:  2011-10-08       Impact factor: 4.384

3.  Robust size control of bovine serum albumin (BSA) nanoparticles by intermittent addition of a desolvating agent and the particle formation mechanism.

Authors:  Sae-Yeol-Rim Paik; Hoang Hai Nguyen; Jina Ryu; Jeong-Hwan Che; Tae Seok Kang; Jong Kwon Lee; Chi Won Song; Sanghoon Ko
Journal:  Food Chem       Date:  2013-04-29       Impact factor: 7.514

4.  Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill.

Authors:  M B Hansen; S E Nielsen; K Berg
Journal:  J Immunol Methods       Date:  1989-05-12       Impact factor: 2.303

5.  Optimization of PEGylation conditions for BSA nanoparticles using response surface methodology.

Authors:  Hasan Kouchakzadeh; Seyed Abbas Shojaosadati; Amir Maghsoudi; Ebrahim Vasheghani Farahani
Journal:  AAPS PharmSciTech       Date:  2010-08-03       Impact factor: 3.246

6.  Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties.

Authors:  M Merodio; A Arnedo; M J Renedo; J M Irache
Journal:  Eur J Pharm Sci       Date:  2001-01       Impact factor: 4.384

7.  The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion.

Authors:  Saber M Hussain; Amanda K Javorina; Amanda M Schrand; Helen M Duhart; Syed F Ali; John J Schlager
Journal:  Toxicol Sci       Date:  2006-05-19       Impact factor: 4.849

8.  Influence of gold nanoparticles on the kinetics of α-synuclein aggregation.

Authors:  Yanina D Alvarez; Jonathan A Fauerbach; Jésica V Pellegrotti; Thomas M Jovin; Elizabeth A Jares-Erijman; Fernando D Stefani
Journal:  Nano Lett       Date:  2013-11-18       Impact factor: 11.189

9.  Optimization of an anti-HER2 monoclonal antibody targeted delivery system using PEGylated human serum albumin nanoparticles.

Authors:  Hasan Kouchakzadeh; Seyed Abbas Shojaosadati; Fathollah Tahmasebi; Fazel Shokri
Journal:  Int J Pharm       Date:  2013-02-27       Impact factor: 5.875

10.  In vitro toxicity of different-sized ZnO nanoparticles in Caco-2 cells.

Authors:  Tianshu Kang; Rongfa Guan; Xiaoqiang Chen; Yijuan Song; Han Jiang; Jin Zhao
Journal:  Nanoscale Res Lett       Date:  2013-11-21       Impact factor: 4.703

View more
  2 in total

1.  Chitosan-coated bovine serum albumin nanoparticles for topical tetrandrine delivery in glaucoma: in vitro and in vivo assessment.

Authors:  Salma El-Sayed Radwan; Riham M El-Moslemany; Radwa A Mehanna; Eman H Thabet; Elsayeda-Zeinab A Abdelfattah; Amal El-Kamel
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

2.  Green Synthesis of Highly Dispersed Zinc Oxide Nanoparticles Supported on Silica Gel Matrix by Daphne oleoides Extract and their Antibacterial Activity.

Authors:  Laleh Safavinia; Mohammad Reza Akhgar; Batool Tahamipour; Sayed Ali Ahmadi
Journal:  Iran J Biotechnol       Date:  2021-01-01       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.